Albumin clinical trials

Explore recruiting albumin clinical trials.

Recruiting albumin studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Albumin trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The Effect of Albumin Levels on Pharmacokinetics of Cefazolin in Adult Cardiac Surgery: A Prospective, Randomized, Open-label, Parallel-group Pharmacokinetic Study

Austria

Therapeutic use (Phase IV) EU CTIS Study details

HALT : Influence of Human Albumin supplementation on kidney dysfunction after Liver Transplantation

France

Therapeutic use (Phase IV) EU CTIS Study details

Comparison of albumin and Ringer´s solution for optimization of the plasma volume and hemodynamics during surgery

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

(20186 - FIONA OLE) An 18-month, open-label, single-arm safety extension study of an age-and bodyweight-adjusted oral finerenone regimen, in addition to an ACEI or ARB, for the treatment of children and young adults from 1 to 18 years of age with chronic kidney disease and proteinuria

France, Hungary, Portugal, Austria, Finland, Denmark +11 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy, safety, and pharmacokinetics of NNC0519-0130 once weekly s.c. versus semaglutide 1.0 mg and placebo in people with chronic kidney disease, with or without type 2 diabetes, and with overweight or obesity: a proof-of-concept and dose-finding study

Poland, Bulgaria, Italy, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Impact of Albumin on Renal function in critically ill patients with Septic Shock and a high risk of Acute Kidney Injury. A Randomized Controlled Trial.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Albumin trials by city

Albumin in Toronto Albumin in Vancouver Albumin in Montreal Albumin in Calgary Albumin in Edmonton Albumin in Ottawa Albumin in Winnipeg Albumin in Quebec City Albumin in Hamilton Albumin in Kitchener Albumin in London Albumin in Halifax Albumin in New York Albumin in Los Angeles Albumin in Chicago Albumin in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease